Contents

Mini-Reviews in Medicinal Chemistry, Volume 1 - Number 2

The Therapeutic Potential for Catalytic Antibodies From a Concept to a Promise

, 1(2): 125 - 132

Lyn H. Jones and Paul Wentworth


DOI: 10.2174/1389557013407070




Leucine Aminopeptidase as a Target for Inhibitor Design

, 1(2): 133 - 144

J. Grembecka and P. Kafarski


DOI: 10.2174/1389557013406990




Therapeutic Applications of Sugar-Mimicking Glycosidase Inhibitors

, 1(2): 145 - 154

Naoki Asano, Atsushi Kato and Alison A. Watson


DOI: 10.2174/1389557013407052




Origin of Chiral Pharmacology Stereochemistry in Metalloprotease Inhibition

, 1(2): 155 - 161

D. H. Kim


DOI: 10.2174/1389557013407016




Tacrine-Huperzine A Hybrids (Huprines) A New Class of Highly Potent and Selective Acetylcholinesterase Inhibitors of Interest for the Treatment of Alzheimer Disease

, 1(2): 163 - 174

P. Camps and D. Munoz-Torrero


DOI: 10.2174/1389557013406972




beta-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer Disease Dream or Reality?

, 1(2): 175 - 186

Patrice Talaga


DOI: 10.2174/1389557013407098




Quantitative Structure-Activity Relationship (QSAR) Paradigm - Hansch Era to New Millennium

, 1(2): 187 - 195

Asim Kumar Debnath


DOI: 10.2174/1389557013407061




Pharmaceutical Target Identification by Gene Expression Analysis

, 1(2): 197 - 205

Micheal G. Walker


DOI: 10.2174/1389557013407034




Antihypertensive Drugs that Act on Renin-Angiotensin System with Emphasis in AT1 Antagonists

, 1(2): 207 - 217

T. Mavromoustakos, V. Apostolopoulos and J. Matsoukas


DOI: 10.2174/1389557013407115




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science